1. Home
  2. EQ vs STXS Comparison

EQ vs STXS Comparison

Compare EQ & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.28

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$0.83

Market Cap

86.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQ
STXS
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.4M
86.4M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
EQ
STXS
Price
$1.28
$0.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
3
Target Price
★ $8.56
$2.67
AVG Volume (30 Days)
312.5K
★ 881.2K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 16.67
EPS
N/A
★ N/A
Revenue
★ $41,095,000.00
$29,346,617.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.42
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.16
$0.80
52 Week High
$6.20
$2.86

Technical Indicators

Market Signals
Indicator
EQ
STXS
Relative Strength Index (RSI) 40.62 35.89
Support Level $1.24 $0.80
Resistance Level $1.51 $1.97
Average True Range (ATR) 0.12 0.10
MACD 0.01 -0.00
Stochastic Oscillator 15.79 7.39

Price Performance

Historical Comparison
EQ
STXS

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: